| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 23 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 26,300 | $1.34 | $35,312.00 | +0.1% | |
| Nov 24, 2021 | Lee Willis C | Vice Chairman &COO | Buy | 38,000 | $1.34 | $50,850.00 | +13.9% | |
| Nov 22, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 27,000 | $1.41 | $38,130.00 | +0.1% | |
| Nov 22, 2021 | Lee Willis C | Vice Chairman &COO | Buy | 18,600 | $1.38 | $25,649.00 | +3.1% | |
| Nov 18, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 33,000 | $1.28 | $42,310.00 | - | |
| Oct 20, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 1,000 | $1.57 | $1,570.00 | - | |
| Oct 6, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 3,000 | $1.61 | $4,840.00 | - | |
| Sep 27, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 1,000 | $1.64 | $1,640.00 | - | |
| Sep 24, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 2,500 | $1.69 | $4,235.00 | - | |
| Sep 22, 2021 | Niihara Yutaka | Chairman And CEO | Buy | 3,582 | $1.68 | $6,016.86 | - |